Revolutionizing Neuroscience: UCLA's Commitment to Understanding and Treating Brain Disorders
The University of California, Los Angeles (UCLA) is deeply committed to advancing the field of neuroscience through a comprehensive, three-pronged approach. This strategy encompasses cutting-edge treatments for neurological and psychiatric diseases, groundbreaking research into the fundamental workings of the brain, and robust support for collaborative initiatives that bring together experts from diverse disciplines.
The Imperative of Understanding the Brain
At the heart of UCLA's neuroscience endeavor lies the conviction that effective treatments for neuropsychiatric disorders hinge on a thorough understanding of the brain. Just as medical students learn the intricacies of the heart before treating heart disease, or the function of the kidney before addressing kidney ailments, so too must neuroscientists unravel the complexities of the brain to conquer its diseases. The human brain, with its estimated tens of thousands of different types of cells, nearly 100 billion neurons, and a staggering 100 trillion connections, remains an "extraordinary mystery". Unlocking this mystery requires dedicated scholarly inquiry focused on uncovering the root causes of neurological and psychiatric illnesses.
The Laurie and Steven C. Gordon Commitment to Cure Parkinson’s Disease
Philanthropic support plays a crucial role in accelerating neuroscience research at UCLA. The Laurie and Steven C. Gordon Commitment to Cure Parkinson’s Disease, established through a generous $25 million gift in 2018, exemplifies this commitment. This initiative, housed within the David Geffen School of Medicine at UCLA, underscores the Gordon family's dedication to finding a cure for Parkinson's disease. Steven Gordon emphasized the importance of funding in accelerating research, stating that he and Laurie have "seen the difference funding can make."
The Laurie and Steven C. Gordon Chair in Neurosciences
In recognition of their extraordinary contributions, UCLA established the Laurie and Steven C. Gordon Chair in Neurosciences. This endowed chair provides critical resources to support leading neuroscientists in their pursuit of groundbreaking discoveries. Dr. Ming Guo, a distinguished professor of neurology, molecular and medical pharmacology, and director of the UCLA Aging Center, was named the inaugural chair holder. Dr. Guo specializes in research and clinical care for patients with memory, neurodegenerative, and neurogenetic disorders, including Parkinson's disease. Her impressive list of accolades includes the Alfred P. Sloan Research Fellowship, the McKnight Neurobiology of Brain Disorders Award, and the Klingenstein-Simons Fellowship Awards in Neuroscience. Funds from the endowed chair will further empower Dr. Guo's research endeavors.
Dr. Guo expressed her gratitude for the honor, stating, "It is an honor to be the inaugural chair holder, and I am grateful to Laurie and Steven."
Read also: Navigating UCLA Neuroscience PhD
Leadership Perspectives on Philanthropic Impact
UCLA leadership has expressed profound gratitude for the Gordons' unwavering support and vision for neuroscience. Dr. John C. Mazziotta, vice chancellor of UCLA Health Sciences and CEO of UCLA Health, lauded Laurie and Steve as "true philanthropists." Johnese Spisso, president of UCLA Health, CEO of the UCLA Hospital System, and associate vice chancellor of UCLA Health Sciences, extended her "sincere thanks to Steven and Laurie for their incredible support, tireless engagement and vision for neuroscience."
Chancellor Gene D. Block also acknowledged the Gordons' dedication to furthering studies into Parkinson's disease and other neurological conditions, emphasizing the university's deep appreciation for their commitment.
The UCLA Brain Research Institute (BRI): Fostering Collaboration and Innovation
The UCLA Brain Research Institute (BRI) serves as a central hub for neuroscience research, fostering collaboration and innovation across disciplines. The BRI provides multiple mechanisms to invigorate research programs and support collaborations bringing together investigators from complementary fields. UCLA is ranked the #1 public education program in the country by US News.
Research Highlights: Glimpses into Cutting-Edge Studies
UCLA neuroscientists are engaged in a wide range of cutting-edge research projects, exploring diverse aspects of brain function and neurological disorders. Examples of recent publications highlight the breadth and depth of this research:
- Competition, inhibition, and critical periods of cortical plasticity: This research explores the dynamic processes that shape brain development and plasticity, with implications for understanding how the brain adapts to experience.
- Buffering effect of positive parent-child relationships on adolescent risk taking: A longitudinal neuroimaging investigation: This study utilizes neuroimaging techniques to investigate the protective role of positive parent-child relationships in mitigating adolescent risk-taking behaviors.
- Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism: This research examines the relationship between nicotine metabolism, nicotinic receptor availability, and smoking behavior, potentially informing the development of more effective smoking cessation strategies.
- Visible light and near-infrared-responsive chromophores for drug delivery-on-demand applications: This work explores novel drug delivery systems that can be activated by light, offering the potential for targeted and controlled drug release in the brain.
Read also: Opportunities in Neuroscience Education
Read also: Navigating the UCLA Neuroscience Major
tags: #neuroscience #research #building #ucla
